Three years on from the start of the coronavirus pandemic Covid vaccines and antivirals continue to drive Pfizer. And they will keep the group in first place by 2023 prescription drug sales, way ahead of rivals including Merck & Co and Novartis, Evaluate Vantage’s 2023 Preview report finds.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,